Datapoint: Highmark Saves $3M With First CivicaRx Launch

Highmark Inc. members who are taking abiraterone acetate (the generic name for Johnson & Johnson’s Zytiga) have saved an average of $90 per month since a cheaper version of the oncology medication became available through CivicaScript, according to a May 29 press release. Highmark and other Blues plans founded CivicaScript in 2020 to develop generic drugs, including abiraterone acetate, which was the first CivicaScript medication to hit the market in 2022. Since Highmark began prescribing the generic abiraterone acetate in September 2023, the insurer noted its members, group customers and the plan itself has saved nearly $3 million. Highmark said CivicaScript will continue to launch generics, including outpatient drugs that treat specialty areas and chronic health conditions. Highmark currently serves 2,459,151 lives under the pharmacy benefit.

SOURCE: MMIT Analytics, as of 6/3/24

0

0

0 Comments

0

0

• Datapoint